Signaling & Communication
CRISPR Applications in Signaling & Communication
NF-kappaB signaling as a central hub for inflammatory and immune cell communication.(Liu et al., 2017)
NF-kappaB activates anti-apoptotic factors, cell-cycle regulators, cytokines, chemokines, and adhesion molecules, driving dendritic-cell maturation, T-cell differentiation, macrophage polarization, and neutrophil recruitment. Downstream phenotypes include cell survival, proliferation, inflammatory response, angiogenesis, and adhesion/invasion/metastasis - central to inflammatory disease and tumor progression.
Cell signaling—from receptor activation to downstream effectors—governs how cells sense and respond to their environment, coordinating proliferation, differentiation, migration, and survival across tissues and organisms.
Dysregulated signaling underlies cancer, metabolic disease, inflammation, and neurological disorders, making signaling pathways among the most important sources of therapeutic targets.
CRISPR technology enables systematic dissection of signaling networks, from genome-wide screening of pathway regulators to precise perturbation of receptors, kinases, and downstream effectors.
CRISPR technology is transforming signaling research by enabling:
EDITGENE provides integrated CRISPR solutions for signaling and communication research, supporting pathway dissection, screening, model construction, and functional validation.
Signal transduction pathways—including MAPK, PI3K-AKT, JAK-STAT, Wnt, Hedgehog, Notch, and TGF-β—relay extracellular signals to control gene expression and cell behavior. CRISPR enables systematic dissection of these cascades and their regulators.
Cell-surface receptors—including G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and cytokine receptors—initiate signaling in response to ligands. CRISPR enables precise study of receptor function, ligand-receptor interactions, and downstream signaling.
Cells communicate through direct contact and secreted signals—including Notch-Delta signaling, gap junctions, exosomes, and secreted ligands—to coordinate tissue function. CRISPR enables dissection of these intercellular communication mechanisms.
Signaling pathways are among the most important sources of drug targets, with kinases, receptors, and pathway regulators representing major therapeutic opportunities. CRISPR-based screening and functional validation accelerate signaling target discovery.
EDITGENE supports the complete signaling research workflow:
| Research Area | Key Scientific Question | CRISPR Strategy | EDITGENE Support |
| Signal Transduction | Which components control pathway activity? | CRISPR KO, screening | Pathway-reporter models |
| Receptor Signaling | How do receptors initiate signaling? | KO, KI, tagging | Receptor models, signaling assays |
| Cell-Cell Communication | How do cells coordinate through signals? | Gene editing, screening | Co-culture communication models |
| Target Discovery | Which signaling nodes are therapeutic targets? | Genome-wide screening | Target validation, drug response |
Comprehensive Genome Engineering Solutions — EDITGENE provides reliable CRISPR solutions supporting signaling and communication research from concept to validated models.
Advanced Genome Editing Platforms
Proprietary sgRNA Design Algorithms
Pathway Reporter Systems & Endogenous Tagging
Extensive Project Experience
Comprehensive Editing Modes
Rapid Execution & Flexible Customization
Integrated Workflow
Experienced Team
From dissecting signal transduction pathways and receptor signaling to decoding cell-cell communication and discovering therapeutic targets, EDITGENE empowers researchers with reliable CRISPR technologies for next-generation signaling research.
